Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Post by mdjbrownon Oct 26, 2023 1:24pm
109 Views
Post# 35702513

Fellas and gals, any information on this board is helpful

Fellas and gals, any information on this board is helpfulThere is a lot of frustration for sure as things are not moving quickly enough for most, but I truly believe patience will rule the day.

There are a lot of fantastic contributors with amazing incite and once all of these trials conclude and the FDA figures things out with the Epidiolex matters, I would hope that will result in the releasing of the coiled up spring.  Positive numbers in the upcoming financials certainly wont hurt either.

Stay positive folks as Medipharm is one of the very few in this industry poised for success!

According to analysts, this should already be trading in the .15 cent range...............
<< Previous
Bullboard Posts
Next >>